The anti-phospholipid antibody syndrome (Hughes syndrome): therapeutic aspects

This publication has 44 references indexed in Scilit:

• International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: Report of an International workshop
  Arthritis & Rheumatism, 1999
• Outcome of patients with anticardiolipin antibodies: a 10 year follow-up of 52 patients
  Lupus, 1998
• Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk
  The Lancet, 1998
• Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: A four-year prospective study from the italian registry
  The American Journal of Medicine, 1996
• Biochemical characterization of ADP-ribose polymer metabolism in SLE
  Lupus, 1996
• Anti-Cardiolipin Antibodies and Risk of Myocardial Infarction in a Prospective Cohort of Middle-Aged Men
  Circulation, 1995
• Anticardiolipin antibodies are an independent risk factor for first ischemic stroke
  Neurology, 1993
• The Clinical Significance of Autoantibody Profiles in Patients with Systemic Lupus Erythematosus
  Lupus, 1993
• Anticardiolipin Antibodies and the Risk for Ischemic Stroke and Venous Thrombosis
  Annals of Internal Medicine, 1992
• Antiphospholipid Antibodies: Anticardiolipin and the Lupus Anticoagulant in Systemic Lupus Erythematosus (SLE) and in Non-SLE Disorders
  Annals of Internal Medicine, 1990